NASHVILLE, Tenn. - TelAve -- CASPER, Wyo. – Rocky Mountain Oncology is pleased to welcome Sarah Glynn, D.O., a board-certified radiation oncologist, to its team of cancer specialists. Dr. Glynn brings extensive training in advanced radiation therapies, a strong commitment to evidence-based medicine, and a patient-centered approach focused on compassion, communication, and personalized care. She will see patients at Rocky Mountain Oncology's Casper and Lander locations.

A native of Indiana, Dr. Glynn's passion for medicine developed early as she witnessed the meaningful impact her father and grandfather, both radiologists, had on the lives of their patients. Inspired by their example, she pursued a career dedicated to helping individuals facing complex medical challenges.

Dr. Glynn earned her medical degree from the College of Osteopathic Medicine of the Pacific in Pomona, California, completed her Internal Medicine internship at Riverside Community Hospital, and went on to complete her Radiation Oncology residency at Wake Forest University School of Medicine, where she served as Chief Resident. She further advanced her expertise through an intensive brachytherapy fellowship at The University of Texas MD Anderson Cancer Center, specializing in gynecologic and prostate brachytherapy.

More on TelAve News

• Put Your Herd on Your Phone: Kiko Nation Makes Livestock Management Simple
• Future Intelligence Think Tank Surpasses 1,000 Members Exploring Human and Artificial Intelligence
• Gary Bernstein Expands Media Leadership Role With Senior Strategic Advisor Appointment To Blacksun Private Equity
• Headline: House of Nova Paints Every Face in Gold at New York Fashion Week
• Can Government Operate Better Through Innovation?

Throughout her career, Dr. Glynn has emphasized the importance of tailoring treatment plans to each patient's unique diagnosis, goals, and circumstances. She believes that exceptional care is built on a foundation of trust, education, and open communication, empowering patients to make informed decisions throughout their treatment journey.

In addition to her clinical work, Dr. Glynn has pursued research aimed at advancing cancer care and improving patient outcomes. Her research interests include developing genomic signatures to better predict brain metastases and patient outcomes, improving care for patients with extrapulmonary small cell carcinoma, and leading quality improvement initiatives that strengthen collaboration among specialties to enhance radiation treatment planning.

"Every patient deserves cancer care that is both scientifically advanced and deeply personal," said Dr. Glynn. "I believe in taking the time to listen, answer questions, and ensure patients feel supported and informed throughout treatment. It is a privilege to care for individuals and families during such an important time in their lives."

More on TelAve News

• Michael H. Kaplan Advocates for Seriously Injured Colorado Workers Who Need In-Home Care
• Infinity Infusion Solutions Named Finalist for D Magazine's D CEO 2026 Excellence in Healthcare Awards
• Canadian Tint Expo 2027: Why Every Window Tinter Should Compete in Niagara Falls on April 3rd & 4th
• MobileSphere Index Finds Mobile Numbers Are Becoming the New Digital Identity
• Building a Diversified Healthcare Platform as Exosome Science, Telehealth, Diagnostics & Strategic Acquisitions Converge: NexTel Medical (OTCID: MAJI)

As part of the Rocky Mountain Oncology team, Dr. Glynn will collaborate closely with medical oncologists, surgeons, and other specialists to provide comprehensive, multidisciplinary cancer care. Her addition further expands Rocky Mountain Oncology's ability to deliver leading-edge treatment close to home for patients across the region.

About Rocky Mountain Oncology

Rocky Mountain Oncology is dedicated to providing comprehensive cancer care through advanced treatment options, clinical expertise, and compassionate support. Through a collaborative, multidisciplinary approach, Rocky Mountain Oncology offers personalized care designed to achieve the best possible outcomes while supporting patients and families throughout the cancer journey.

Media Contact
Amber Mellema
VP Operations
Rocky Mountain Oncology
307-235-5433
amellema@rockymountainoncology.com
https://rockymountainoncology.com/